KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 69 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40 | -9.1% | 4,215 | -14.1% | 0.00% | – |
| Q2 2023 | $44 | -54.6% | 4,906 | -60.5% | 0.00% | – |
| Q1 2023 | $97 | +115.6% | 12,413 | +88.9% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 6,572 | +148.1% | 0.00% | – |
| Q3 2022 | $38,000 | +100.0% | 2,649 | +34.5% | 0.00% | – |
| Q2 2022 | $19,000 | -64.8% | 1,970 | -45.8% | 0.00% | – |
| Q1 2022 | $54,000 | -93.0% | 3,638 | -93.7% | 0.00% | – |
| Q4 2021 | $766,000 | +323.2% | 57,972 | +457.2% | 0.00% | – |
| Q3 2021 | $181,000 | +48.4% | 10,404 | +105.2% | 0.00% | – |
| Q2 2021 | $122,000 | -85.7% | 5,069 | -84.8% | 0.00% | – |
| Q1 2021 | $854,000 | +228.5% | 33,283 | +143.3% | 0.00% | – |
| Q4 2020 | $260,000 | +40.5% | 13,680 | -6.7% | 0.00% | – |
| Q3 2020 | $185,000 | +9.5% | 14,658 | +4.7% | 0.00% | – |
| Q2 2020 | $169,000 | +106.1% | 14,001 | +31.1% | 0.00% | – |
| Q1 2020 | $82,000 | -81.5% | 10,679 | -57.1% | 0.00% | – |
| Q4 2019 | $444,000 | +112.4% | 24,896 | +38.1% | 0.00% | – |
| Q3 2019 | $209,000 | -59.0% | 18,034 | -21.6% | 0.00% | – |
| Q2 2019 | $510,000 | -45.2% | 23,007 | -29.2% | 0.00% | -100.0% |
| Q1 2019 | $930,000 | -25.0% | 32,489 | -48.2% | 0.00% | 0.0% |
| Q4 2018 | $1,240,000 | +61900.0% | 62,778 | +88319.7% | 0.00% | – |
| Q3 2018 | $2,000 | -84.6% | 71 | -94.7% | 0.00% | – |
| Q4 2017 | $13,000 | – | 1,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |